87234-24-0
Chemical Structure
Piroxicam cinnamate
Synonym(s): Cinnoxicam; SPA-S-510; Sinartol
- CAS No.: 87234-24-0
- Formula:C24H19N3O5S
- Molecular Weight:461.49
IUPAC Name: 2-methyl-1,1-dioxido-3-(pyridin-2-ylcarbamoyl)-2H-benzo[e][1,2]thiazin-4-yl cinnamate
InChIKey: GPUVGQIASQNZET-CCEZHUSRSA-N
SMILES: O=C(/C=C/C1=CC=CC=C1)OC(C2=CC=CC=C23)=C(C(NC4=CC=CC=N4)=O)N(C)S3(=O)=O
Biological Activity: Piroxicam cinnamate (Cinnoxicam) is a cyclooxygenase (COX) inhibitor, with anti-inflammatory activity. Piroxicam cinnamate is stable under gastric conditions, can be used for inflammatory-degenerative osteoarticular diseases, rheumatic disorders, and varicocele (VC) associated oligoasthenospermia research[1][2][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Piroxicam cinnamate | 99.19% | Piroxicam cinnamate (Cinnoxicam) is a cyclooxygenase (COX) inhibitor, with anti-inflammatory activity. Piroxicam cinnamate is stable under gastric conditions, can be used for inflammatory-degenerative osteoarticular diseases, rheumatic disorders, and varicocele (VC) associated oligoasthenospermia research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Piroxicam cinnamate (Standard) | ≥98% | Piroxicam cinnamate (Standard) is the analytical standard of Piroxicam cinnamate (HY-106583). This product is intended for research and analytical applications. Piroxicam cinnamate (Cinnoxicam) is a cyclooxygenase (COX) inhibitor, with anti-inflammatory activity. Piroxicam cinnamate is stable under gastric conditions, can be used for inflammatory-degenerative osteoarticular diseases, rheumatic disorders, and varicocele (VC) associated oligoasthenospermia research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Poli G, et al. The Role of NLRP3 Inflammasome Activation and Oxidative Stress in Varicocele-Mediated Male Hypofertility. Int J Mol Sci. 2022 May 7;23(9):5233. [Content Brief]
- [2]. Cavallini G, et al. Medical therapy of oligoasthenospermia associated with left varicocele. BJU Int. 2003 Apr;91(6):513-8. [Content Brief]
- [4]. M Nakka, et al. Synthesis, characterization and anti-bacterial screening of Piroxicam based sulfonates. J. Chem. Pharm. Res., 2011, 3(2):581-588.
